ao link
Menu
Business Reporter
Business Reporter

MyCondro™, The Chondroitin to Make The Move

Sponsored by Gnosis
Linked InXFacebook
bookmark_borderSave to Library

MyCondro™ is a fermentation-derived, non-animal chondroitin sulfate that redefines joint health and mobility. Clinically validated at 600 mg, it improves knee function, reduces pain, and lowers inflammation markers. Its low molecular weight and superior absorption enable effective low-dose formulations that are vegan, traceable, and free from animal contaminants.

 

The accompanying infographic highlights these benefits, compares MyCondro™ with animal-derived ingredients, and summarizes key data on efficacy, safety, and supply chain transparency. Ideal for athletes, preventive health consumers, and aging populations, MyCondro™ simplifies product development while delivering reliable, science-backed joint support.

 

Download here

Sponsored by Gnosis
Linked InXFacebook
bookmark_borderSave to Library

Download Now

I understand and agree that Lyonsdown Limited may collect and process my personal data and pass on the same to Gnosis for Gnosis's marketing purposes as governed by their Privacy Policy.

I agree

I hereby provide my explicit consent for Lyonsdown Limited to use my personal data for their marketing purposes as governed by our Terms of Use and Privacy Policy.

I agree
Business Reporter

Subscribe to our Weekly Newsletter

Receive the latest insights direct to your inbox, and gain access to our exclusive events.
Business Reporter

Winston House, 3rd Floor,
Units 306-309, 2-4 Dollis park,
London, N3 1HF

 

020 8349 4363

info@business-reporter.co.uk

 © 2026, Lyonsdown Limited. teiss® is a registered trademark of Lyonsdown Ltd. VAT registration number: 830519543